CD28; a costimulatory activator of T-cells is expressed on all CD4+ T-cells and half of CD8+ T-cells.
CTLA-4, cytotoxic T-lymphocyte-associated antigen, an inhibitor of T-cell activation
ICOS, inducible costimulator
BTLA, B- and T-lymphocyte attenuator
PD-1, an inhibitor of T-and B-cells, is expressed by activated T-cells, B-cells and myeloid cells.
There are two known ligands for PD-1; PD-L1 and PD-L2.
An antibody against PD-1 has been raised that is immunoreactive in paraffin-embedded tissues1.
In tonsils, on T-cells and some B-cells of the light zone of germinal centres.
NOT by fetal or adult thymic cells
By angioimmunoblastic lymphoma but not by other lymphomas:
0/31 |
|||
0/41 |
|||
0/41 |
|||
0/61 |
|||
0/31 |
|||
0/31 |
|||
0/61 |
|||
0/71 |
|||
0/31 |
|||
0/31 |
|||
B-cell lymphoma |
0/421 |
||
0/111 |
|||
0/14 (the T-cells forming rosettes around L&H cells are positive)1 |
|||
0/51 |
|||
0/31 |
|||
23/23 (a subset of the positive cells are also positive for CD10 and bcl-6. The follicular dendritic cells adjacent to the PD-1 positive T-cells stain for PD-L1)1 |
|||
0/141 |
|||
0/121 |
|||
0/31 |
|||
Potentially in the diagnosis of Angioimmunoblastic lymphoma.
References
This page last revised 12.7.2006.
©SMUHT/PW Bishop